Daily Cosmetic Research Analysis
Across aesthetics-focused care, a network meta-analysis supports tissue adhesives for minimally invasive surgery port-site closure due to superior cosmetic outcomes without excess complications, a PRISMA-guided review flags endocrine and reproductive concerns with common sunscreen UV filters, and a systematic review in septorhinoplasty highlights opioid overprescription and effective opioid-sparing strategies.
Summary
Across aesthetics-focused care, a network meta-analysis supports tissue adhesives for minimally invasive surgery port-site closure due to superior cosmetic outcomes without excess complications, a PRISMA-guided review flags endocrine and reproductive concerns with common sunscreen UV filters, and a systematic review in septorhinoplasty highlights opioid overprescription and effective opioid-sparing strategies.
Research Themes
- Evidence-based wound closure for better cosmesis
- Sunscreen UV filter endocrine and reproductive safety
- Opioid-sparing analgesia in aesthetic surgery
Selected Articles
1. Optimal port site skin closure method following minimally-invasive surgery: A systematic review and network meta-analysis of randomised clinical trials.
Across 19 RCTs (n=1,932), tissue adhesives achieved superior cosmetic outcomes for MIS port-site closure without significant differences in wound complications, infection, dehiscence, or pain, although a trend toward higher dehiscence with adhesives was noted. Findings support adhesives as a primary closure option while underscoring vigilance for dehiscence.
Impact: This NMA synthesizes randomized evidence to guide an everyday surgical choice that directly affects scarring and patient satisfaction, clarifying trade-offs between cosmesis and dehiscence risk.
Clinical Implications: Consider tissue adhesives as first-line for MIS port-site skin closure to optimize scar appearance, paired with protocols for dehiscence monitoring and patient selection (e.g., tension, location, comorbidity).
Key Findings
- Nineteen RCTs (n=1,932) compared 8 closure methods (sutures, tissue glues, staples, paper-tape).
- No significant differences across methods in wound complications, infection, dehiscence, or pain.
- Tissue adhesives produced superior cosmetic outcomes at early and late follow-up.
- A trend toward higher dehiscence rates with adhesives was observed.
Methodological Strengths
- PRISMA-NMA compliant network meta-analysis of randomized trials
- Broad comparison across multiple closure modalities with indirect and direct evidence synthesis
Limitations
- Potential heterogeneity in outcome assessment and follow-up intervals across RCTs
- Observed trend toward higher dehiscence with adhesives needs patient-level analysis to identify moderators
Future Directions: Individual patient data NMA to stratify dehiscence risk (wound tension, BMI, diabetes), cost-effectiveness analyses, and standardized cosmesis metrics for long-term outcomes.
BACKGROUND: For minimally-invasive surgery (MIS), there are numerous acceptable port-site closure techniques with no consensus on the method used. AIM: To identify optimal port site postoperative wound closure method following MIS with respect to complication rates and cosmetic outcome. METHODS: Network meta-analysis (NMA) was performed in accordance with PRISMA-NMA guidelines for RCTs comparing at least two methods of port-site closure. RESULTS: Nineteen RCTs were identified evaluating eight methods of wound closure in 1,932 patients; across three types of suture, three forms of tissue glue, staples and paper-tape. At NMA, there was no significant difference in wound complication, infection, dehiscence or pain rate irrespective of closure method, albeit a trend towards higher rate of dehiscence for adhesives. At NMA, wound cosmesis was superior for adhesives at both early and late postoperative follow-up. CONCLUSION: This study validates the use of tissue adhesives with respect to primary closure of port sites following MIS while highlighting potential associated risks.
2. Endocrine and Reproductive Health Considerations of Sunscreen UV Filters: Insights from a Comprehensive Review 2014-2024.
A PRISMA-guided synthesis of 75 human/epidemiological studies links certain organic UV filters—especially benzophenones—to hormonal disruptions (testosterone reduction in adolescent males, thyroid alterations in pregnancy), pubertal timing shifts, decreased sperm quality, and mixed prenatal outcomes. The review balances photoprotection benefits with evidence gaps, calling for long-term mixed-exposure studies and safer alternatives.
Impact: Sunscreen use is ubiquitous; synthesizing human data on endocrine and reproductive risks directly informs public health guidance, regulatory policy, and formulation choices.
Clinical Implications: Advise continued photoprotection while minimizing unnecessary chemical UV filter exposure (e.g., use of mineral sunscreens in sensitive groups) and monitor at-risk populations (adolescents, pregnant women) as evidence evolves.
Key Findings
- PRISMA-guided review of 75 human/epidemiological studies on organic UV filters with emphasis on benzophenones (BP-3, BP-2, 4-OHBP).
- Associations with reduced testosterone in adolescent males and altered thyroid hormones in pregnant women.
- Links to delayed puberty in boys and earlier menarche in girls; decreased sperm quality and motility in men.
- Mixed prenatal outcomes, including changes in neonatal size, gestational age, and placental-to-birth weight ratios.
- Mixed exposures to multiple UV filters show cumulative and complex endocrine effects.
Methodological Strengths
- PRISMA-guided comprehensive screening and inclusion of human/epidemiologic evidence
- Focus on real-world mixed exposures reflecting cumulative effects
Limitations
- Heterogeneity of exposure assessment and outcomes limits causal inference
- Lack of quantitative meta-analysis and residual confounding in observational data
Future Directions: Prospective longitudinal cohorts with standardized biomonitoring, mixture modeling of UV filter co-exposures, and development/testing of safer sunscreen alternatives.
PURPOSE OF REVIEW: Chemical (organic) ultraviolet (UV) filters-carbon-based compounds widely used in sunscreen formulations-are essential for protecting against harmful UV radiation. However, emerging evidence over the last decade (2014-2024) has raised concerns regarding their potential endocrine-disrupting effects, environmental persistence, and bioaccumulation. This comprehensive review evaluates the endocrine, reproductive, and developmental health impacts of organic UV filters, with a focus on benzophenone derivatives such as BP-3, BP-2, and 4-OHBP. RECENT FINDINGS: The analysis incorporates data from 75 studies identified through PRISMA-guided screening of epidemiological and human research. Findings reveal significant hormonal disruptions, including reduced testosterone levels in adolescent males, altered thyroid hormones in pregnant women, and associations with delayed pubertal development in boys and early menarche in girls. Mixed exposures to multiple UV filters, frequently occurring in real-world scenarios, demonstrate cumulative and complex effects, particularly on thyroid hormone levels and reproductive health. In men, benzophenones are associated with decreased sperm quality and motility, while in women, their impact on ovarian reserve and fertility outcomes appears less pronounced. Prenatal exposure studies show mixed outcomes, ranging from reduced neonatal size and gestational age to increased placental-to-birth weight ratios. This review underscores the dual nature of organic UV filters, emphasizing their importance in photoprotection while highlighting the need for a balanced approach to safety evaluations. Future research should prioritize long-term cohort studies, assessments of mixed exposure effects, and the development of safer alternatives. Addressing these challenges is crucial for mitigating risks to human health and the environment while maintaining the protective benefits of sunscreens.
3. Management of Postoperative Pain in Septorhinoplasty: A Systematic Review.
Across 14 studies, septorhinoplasty patients were prescribed substantially more opioids than they consumed, while alternatives such as sphenopalatine ganglion block, gabapentin, and NSAIDs achieved comparable or superior analgesia. Limited evidence also supports vibration therapy, underscoring opportunities for multimodal opioid-sparing regimens.
Impact: This review targets a highly common cosmetic-functional surgery and provides concrete avenues to reduce opioid exposure without sacrificing pain control.
Clinical Implications: Adopt multimodal analgesia prioritizing NSAIDs (e.g., ibuprofen, celecoxib), gabapentin, and regional blocks; right-size opioid prescriptions based on typical consumption patterns.
Key Findings
- Among five opioid-focused studies, patients received 10–60 tablets but used only 4.9–14.7 tablets.
- Pharmacologic alternatives (sphenopalatine ganglion block, gabapentin, NSAIDs) provided equivalent or better pain control versus opioids.
- A nonpharmacologic intervention (vibration therapy) reduced pain scores in one study.
- Heterogeneity across studies suggests a need for standardized protocols and outcomes.
Methodological Strengths
- PRISMA-adherent systematic review across multiple databases
- Independent dual-reviewer screening and quality appraisal (CASP/NICE tools)
Limitations
- Heterogeneous designs and outcomes, precluding robust meta-analysis
- Limited high-quality RCT data for some alternatives and nonpharmacologic modalities
Future Directions: Conduct adequately powered RCTs comparing multimodal regimens, standardize pain and function outcomes, and develop prescribing guidelines tailored to septorhinoplasty.
OBJECTIVE: Septorhinoplasties are a common surgery. Effectively managing postoperative pain and identifying opioid reduction techniques is of critical importance. This systematic review characterizes the literature regarding the management of postoperative pain with opioid-based and opioid alternative therapies in patients undergoing septorhinoplasty. DATA SOURCES: Medline (Ovid), Embase (Elsevier), Cochrane Library (Wiley), and Web of Science (Clarivate). REVIEW METHODS: A literature search was conducted using multiple medical subject headings (MeSH) and keywords with adherence to preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. Full-text analysis was performed by two independent reviewers using the Critical Appraisal Skills Program (CASP) and National Institute for Health and Clinical Excellence (NICE) validated quality assessment tools. RESULTS: A total of 2503 articles were identified, and 14 studies met inclusion criteria. In the five opioid-based studies, patients were prescribed 10-60 opioid tablets, with consumption of 4.9-14.7 opioid tablets. Six pharmacologic opioid alternative therapy studies included sphenopalatine ganglion block, gabapentin, and nonsteroidal anti-inflammatory drugs (NSAIDs), all of which demonstrated either equivalent or improved pain control compared to opioid medications. Three nonpharmacologic opioid alternative studies were included, and one showed that vibration therapy reduced pain scores. CONCLUSION: While studies examining postoperative pain control in septorhinoplasty are heterogeneous, our findings suggest that opioids are prescribed in excess of exhibited need. Areas of consideration for opioid alternative multimodal pain control include gabapentin, celecoxib, ibuprofen, or other NSAID therapies, and local anesthetic blocks. Additional studies are needed to further examine minimizing opioids in postoperative pain control.